The results of serum sample testing showed that these mAbs, as described above, specifically identified the proteins S100A8, S100A9 and S100A12 in the serum and were able to evaluate changes in the protein content of S100A8, S100A9, and S100A12 during infection. This evidence concerns the gene S100A9 and infection.